This study aims to show that enzyme control of cephalexin reactive crystallization can produce crystals with a more desirable aspect ratio while also providing the benefits of combined synthesis and separation (greater productivity, conversion). The mechanism of PGA synthesis of beta-lactam antibiotics such as cephalexin is known (McDonald et al. 2017); here an immobilized form of PGA is used to enable recycling of the enzyme. Use of process analytical technology (PAT) combined with a reaction-diffusion-crystallization model (Salami et al. 2020, in preparation) lends insight into the phenomena critical to successful implementation of this novel means of supersaturation control. In situ microscopy and focused beam reflectance measurement (FBRM) show that the amount of crystal surface area is important to both aspect ratio and secondary nucleation. The model suggests that the amount of enzyme, and unexpectedly the immobilized bead size, is critical in dictating the reaction timescale. In general, this study demonstrates how catalysts can lend control over the crystallization process, giving process designers an additional knob to turn in the synthesis of new routes to important pharmaceutical products.
Li, M., et al. (2019). "Optimizing the Aspect Ratio of Cephalexin in Reactive Crystallization by Controlling Supersaturation and Seeding Policy." Transactions of Tianjin University 25(4): 348-356.
McDonald, M. A., et al. (2017). "Enzymatic reactive crystallization for improving ampicillin synthesis." Chemical Engineering Science 165: 81-88.
Salami, H., et al. (2020). âModel development for enzymatic reactive crystallization of β-lactam antibiotics, a reaction-diffusion-crystallization modeling approach.â Computers & Chemical Engineering in preparation